Join this webinar to learn more about the 2025 Milner Consortium Call.

Our pharma partners in the Milner Therapeutics Consortium have identified topics for challenges that are a current priority for external collaboration with academics. These projects could provide a better understanding of a disease mechanism or discover and validate new therapeutic targets and can range from reagent sharing and 6-month pilots to 2-year postdoctoral funded collaborations. They are expected to lead to joint publications with the company partners.

Are you an academic at the University of Cambridge, Babraham and Wellcome Sanger Institutes? Do you have an idea for a potential pre-clinical collaborative project that would benefit from industry expertise and know-how? We are looking for project proposals that could provide solutions to current challenges in the following areas, and applications from cross-disciplinary teams are encouraged:

Neuroscience – Immunology & Inflammation – New technologies – Infectious Disease – Reproductive Medicine – Oncology – Metabolism and Cardiovascular disease

Information webinar
To learn more, please register to attend our information and Q&A webinar, taking place on 27 January at 2pm.

Contact details:
For full details, to download FAQs and an application form, please visit: https://www.milner.cam.ac.uk/consortiumcall